A Study of Retatrutide (LY3437943) on Renal Function in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes
Clinical trial NCT05936151 · COMPLETED
Trial details
- NCT number
- NCT05936151
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-20
- Primary completion
- 2025-10-01
- Enrollment
- 146
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.